These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8116183)

  • 1. Design and analysis of veterinary vaccine efficacy trials.
    Tanner JE; Morgan AP
    Vet Microbiol; 1993 Nov; 37(3-4):221-30. PubMed ID: 8116183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 3. Statistical methods for analysis of in vitro antigen quantification data for veterinary biologic products.
    Wilbur LA
    Vet Microbiol; 1993 Nov; 37(3-4):231-40. PubMed ID: 8116184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency as tool to support in vitro batch potency testing in GMP production.
    Stirling C
    Dev Biol (Basel); 2012; 134():115-8. PubMed ID: 22888603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern veterinary vaccines and the Shaman's apprentice.
    Carter PB; Carmichael LE
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):389-400. PubMed ID: 12818624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [How can the practicing veterinarian select the best vaccine?].
    van Oirschot JT
    Tijdschr Diergeneeskd; 1996 Oct; 121(20):582-5. PubMed ID: 8966705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veterinary and human vaccine evaluation methods.
    Knight-Jones TJ; Edmond K; Gubbins S; Paton DJ
    Proc Biol Sci; 2014 Jun; 281(1784):20132839. PubMed ID: 24741009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress and future directions for reduction, refinement, and replacement of animal use in veterinary vaccine potency and safety testing: a report from the 2010 NICEATM-ICCVAM International Vaccine Workshop.
    Stokes WS; Kulpa-Eddy J; Brown K; Srinivas G; McFarland R
    Dev Biol (Basel); 2012; 134():9-21. PubMed ID: 22888590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consistency as an alternative to potency testing.
    Duchow K
    Dev Biol (Basel); 2012; 134():119-22. PubMed ID: 22888604
    [No Abstract]   [Full Text] [Related]  

  • 10. The validation of potency tests: hurdles identified by EMA/CVMP/IWP.
    Woodland R
    Dev Biol (Basel); 2012; 134():69-73. PubMed ID: 22888597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.
    Krämer B; Kamphuis E; Hanschmann KM; Milne C; Daas A; Duchow K
    Biologicals; 2013 Nov; 41(6):400-6. PubMed ID: 24144483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency testing of veterinary vaccines: the way from in vivo to in vitro.
    Romberg J; Lang S; Balks E; Kamphuis E; Duchow K; Loos D; Rau H; Motitschke A; Jungbäck C
    Biologicals; 2012 Jan; 40(1):100-6. PubMed ID: 22075457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Batch safety testing of veterinary vaccines - potential welfare implications of injection volumes.
    Cooper J
    Altern Lab Anim; 2008 Dec; 36(6):685-94. PubMed ID: 19154094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veterinary Replicon Vaccines.
    Hikke MC; Pijlman GP
    Annu Rev Anim Biosci; 2017 Feb; 5():89-109. PubMed ID: 27860492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs.
    De Mattia F; Chapsal JM; Descamps J; Halder M; Jarrett N; Kross I; Mortiaux F; Ponsar C; Redhead K; McKelvie J; Hendriksen C
    Biologicals; 2011 Jan; 39(1):59-65. PubMed ID: 21277791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards in vitro potency testing of inactivated erysipelas vaccines.
    Balks E; Wolf C; Loessner H; Werner E
    Dev Biol (Basel); 2012; 134():37-44. PubMed ID: 22888593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency testing of veterinary rabies vaccines: replacement of challenge by in vitro testing: considerations for development of alternative assays.
    Lewis CE; Fry AM; Hermann JR; Siev D; Dusek DM; Gatewood DM
    Dev Biol (Basel); 2012; 134():29-33. PubMed ID: 22888592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro potency assays for nonreplicating veterinary vaccines: comparison to in vivo assays and considerations in assay development.
    Levings RL; Henderson LM; Metz CA
    Vet Microbiol; 1993 Nov; 37(3-4):201-19. PubMed ID: 8116182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.